SpringerProtocols: Abstract: Antibodies Against Huntingtin: Production and Screening of Monoclonals and Single-Chain Recombinant Forms

Antibodies Against Huntingtin: Production and Screening of Monoclonals and Single-Chain Recombinant Forms

By: Ali Khoshnan², Susan Ou², Jan Ko², Paul H. Patterson²

Abstract

Full Text

Download PDF (207K)

Antibodies can be extremely useful tools for the field of triplet repeat diseases. These reagents are important for localizing proteins in tissues, and within cells, they can be used in the isolation and characterization of the components of protein complexes, they can distinguish proteins with normal or an expanded polyglutamine repeat, they may be able to distinguish distinct conformations of a protein, and they can be used to perturb the function of proteins in living cells. Our group has produced monoclonal and recombinant single-chain antibodies that can be used for each of these purposes with huntingtin. This is the protein that, when mutated to contain an expanded polyQ motif, causes Huntington’s disease.

Affiliation(s): (2) Biology Division, California Institute of Technology, Pasadena, CA

Book Title: Trinucleotide Repeat Protocols

Series: Methods in Molecular Biology | Volume: 277 | Pub. Date: Jun-18-2004 | Page Range: 87-102 | DOI: 10.1385/1-59259-804-8:087

Subject: Cell Biology

Key Words: MAb - scFv - huntingtin

References

Download References

1.	Bennett, M. J., Huey-Tubman, K. E., Herr, A. B., et al. (2002) A linear lattice model for polyglutamine in CAG-expansion diseases. Proc. Natl. Acad. Sci. USA 99, 11,634–11,639.

2.	Ko, J., Ou, S., and Patterson, P. H. (2001) New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Brain Res. Bull. 56, 319–329.

3.	Ko, J. and Patterson, P. H. Unpublished data.

4.	Khoshnan, A., Ko, J., and Patterson, P. H. (2002) Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity. Proc. Natl. Acad. Sci. USA 99, 1002–1007.

5.	Jackson, J. R., Salecker, I., Dong, X., et al. (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633–642.

6.	Jackson, G., Khoshnan, A., and Patterson, P. H. Unpublished data.

7.	Khoshnan, A., Reinhart, P., and Patterson, P. H. Unpublished data.

8.	Harlow, E. and Lane, D. (1988) Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 55–56 and 72–73.

9.	Gullick, W. J. (1988) Production of antiserum to synthetic peptides. Methods Mol. Biol. 3, 341–354.

10.	Hawkes, R., Niday, E., and Gordan, J. (1982) A dot-immunobinding assay for monoclonal and other antibodies. Anal. Biochem. 119, 142–147.

11.	Al Moudallal, Z., Altschuh, D., Briand, J. P., et al. (1984) Comparative sensitivity of different ELISA procedures for detecting monoclonal antibodies. J. Immunol. Methods 68, 35–43.

12.	Birk, H.-W. and Koepsell, H. (1987) Reaction of monoclonal antibodies with plasma membrane proteins after binding on nitrocellulose: renaturation of antigenic binding sites and reduction of nonspecific antibody binding. Anal. Biochem. 164, 12–22.

13.	Davies, D. R., Padlan, E. A., and Sheriff, S. (1990) Antibody-antigen complexes. Annu. Rev. Biochem. 59, 439–473.

14.	Ou, S. K. and Patterson, P. H. (1997) A more efficient and economical approach for monoclonal antibody production. J. Immunol. Methods 209, 105–108.

15.	Stang, B. V., Wood, P. A., Reddington, J. J., et al. (1998) Monoclonal antibody production in gas-permeable flexible flasks, using serum-free medium. Contemp. Topics 37, 55–60.

16.	Scott, L. E., Aggett, H., and Glencross, D. K. (2001) Manufacture of pure monoclonal antibodies by heterogeneous culture without downstream purification. Biotechnique 31, 666–668.

17.	Jackson, L. R., Trudel, L. J., and Lipman, N. S. (1999) Small-scale monoclonal antibody production in vitro: methods and resources. Lab. Anim. 28, 20–30.

18.	Marx, U., Embleton, M. J., Fischer, R., et al. (1997) Monoclonal antibody production. The report and recommendations of ECVAM workshop 23. Altern. Lab. Anim. 25, 121–137.

19.	Ou, S. K., Hwang, J. M., and Patterson, P. H. (1993) A modified method for obtaining large amounts of high titer polyclonal ascites fluid. J. Immunol. Methods 165, 75–80.

20.	Rondon, I. J. and Marasco, W. A. (1997) Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51, 257–283.

21.	Lecerf, J.-M., Shirley, T. L., Zhu, Q., et al. (2001) Human single chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington’s disease. Proc. Natl. Acad. Sci. USA 98, 4764–4769.

22.	Winter, G. (1998) Making antibody and peptide ligands by repertoire selection technologies. J. Mol. Recog. 11, 126–127.

23.	Khoshnan, A., Ko, J., Paige, L., et al. Submitted.

24.	Matthew, W. D. and Sandrock, A. W. (1987) Cyclophosphamide treatment used to manipulate the immune response for the production of monoclonal antibodies. J. Immunol. Methods 100, 73–82.

25.	Lebron, J. A., Shen, H., Bjorkman, P. J., et al. (1999) Tolerization of adult mice to immunodominant proteins before monoclonal antibody production. J. Immunol. Methods 222, 59–63.

26.	Lipman N. S., Trudel L. J., Murphy J. C., et al. (1992) Comparison of immune response potentiation and in vivo inflammatory effects of Freund’s and RIBI adjuvants in mice. Lab. Anim. Sci. 42, 193–197.

27.	Rudbach, J. A., Cantrell, J. L., and Ulrich, J. T. (1988) Molecularly engineered microbial immunostimulators, in Technological Advances in Vaccine Development (L. Lasky, ed.), Alan R. Liss, New York, pp. 443–454.

Comments (Loading...)

Post comment/View all comments